11,000
Participants
Start Date
October 24, 2025
Primary Completion Date
October 29, 2030
Study Completion Date
October 29, 2030
Zilebesiran
Zilebesiran will be administered SC
Placebo
Placebo will be administered SC
RECRUITING
Clinical Trial Site, New Windsor
RECRUITING
Clinical Trial Site, Jacksonville
RECRUITING
Clinical Trial Site, Orlando
RECRUITING
Clinical Trial Site, Melbourne
RECRUITING
Clinical Trial Site, Miami
RECRUITING
Clinical Trial Site, Palm Springs
RECRUITING
Clinical Trial Site, Brandon
RECRUITING
Clinical Trial Site, Tampa
RECRUITING
Clinical Trial Site, Chattanooga
RECRUITING
Clinical Trial Site, Knoxville
RECRUITING
Clinical Trial Site, Columbus
RECRUITING
Clinical Trial Site, Maumee
RECRUITING
Clinical Trial Site, Cincinnati
RECRUITING
Clinical Trial Site, Valparaiso
RECRUITING
Clinical Trial Site, Evansville
RECRUITING
Clinical Trial Site, Fargo
RECRUITING
Clinical Trial Site, Flossmoor
RECRUITING
Clinical Trial Site, Little Rock
RECRUITING
Clinical Trial Site, Plano
RECRUITING
Clinical Trial Site, McKinney
RECRUITING
Clinical Trial Site, Mesquite
RECRUITING
Clinical Trial Site, Houston
RECRUITING
Clinical Trial Site, Richmond
RECRUITING
Clinical Trial Site, Houston
RECRUITING
Clinical Trial Site, Missouri City
RECRUITING
Clinical Trial Site, Bountiful
RECRUITING
Clinical Trial Site, Phoenix
RECRUITING
Clinical Trial Site, Tucson
RECRUITING
Clinical Trial Site, Albuquerque
RECRUITING
Clinical Trial Site, Escondido
Lead Sponsor
Hoffmann-La Roche
INDUSTRY
Alnylam Pharmaceuticals
INDUSTRY